Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models
Authors
Keywords
-
Journal
GLIA
Volume 66, Issue 3, Pages 492-504
Publisher
Wiley
Online
2017-11-14
DOI
10.1002/glia.23260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease
- (2017) Steven Deleye et al. JOURNAL OF NUCLEAR MEDICINE
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- The role of peripheral immune cells in the CNS in steady state and disease
- (2017) Marco Prinz et al. NATURE NEUROSCIENCE
- Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
- (2017) T. Harach et al. Scientific Reports
- Regulatory T cells delay disease progression in Alzheimer-like pathology
- (2016) Cira Dansokho et al. BRAIN
- Glial cells as drug targets: What does it take?
- (2016) Thomas Möller et al. GLIA
- Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model
- (2016) Sung Hoon Baik et al. GLIA
- PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
- (2016) Kuti Baruch et al. NATURE MEDICINE
- Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease
- (2016) Henrik H. Hansen et al. PLoS One
- The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function
- (2016) Samuel E. Marsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Aβ Clearance and Degradation by Glial Cells
- (2016) Miriam Ries et al. Frontiers in Aging Neuroscience
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Innate immunity in Alzheimer's disease
- (2015) Michael T Heneka et al. NATURE IMMUNOLOGY
- Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
- (2015) Elena Zenaro et al. NATURE MEDICINE
- Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology
- (2015) Kuti Baruch et al. Nature Communications
- Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
- (2015) Claudia Späni et al. Acta Neuropathologica Communications
- IFN- Production by Amyloid -Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer's Disease
- (2013) T. C. Browne et al. JOURNAL OF IMMUNOLOGY
- Six red flags for suspect work
- (2013) C. Glenn Begley NATURE
- Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice
- (2013) Tina Löffler et al. NEUROBIOLOGY OF AGING
- Systemic Transplantation of Human Umbilical Cord Derived Mesenchymal Stem Cells-Educated T Regulatory Cells Improved the Impaired Cognition in AβPPswe/PS1dE9 Transgenic Mice
- (2013) Hongna Yang et al. PLoS One
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search